Supplementary Figure 5 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Tyler J. Lahusen,Chu-Xia Deng

DOI: https://doi.org/10.1158/1535-7163.22501749.v1

2023-01-01

Abstract:Supplementary Figure 5. Cell viability of WT and ATF3-/- MEFs treated with SRT1720

What problem does this paper attempt to address?

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Wenqun Zhong,Zebin Xiao,Zhiyuan Qin,Jingbo Yang,Yi Wen,Ziyan Yu,Yumei Li,Neil C. Sheppard,Serge Y. Fuchs,Xiaowei Xu,Meenhard Herlyn,Carl H. June,Ellen Puré,Wei Guo

DOI: https://doi.org/10.1158/0008-5472.23907869

2023-01-01

Abstract:Supplementary Figures and Figure Legends
Supplementary Figure 2 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Tyler Lahusen,Chu‐Xia Deng

DOI: https://doi.org/10.1158/1535-7163.22501758

2023-01-01

Abstract:Supplementary Figure 2. Control and SIRT1 knockdown MDA-MB-231 cells treated with a dose range of resveratrol for 24 hours
Supplementary Figure 2 from RON Receptor Tyrosine Kinase As a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Sreedhar Reddy Suthe,Hang-Ping Yao,Tian-Hao Weng,Chen-Yu Hu,Liang Feng,Zhi-Gang Wu,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22505502.v1

2023-01-01

Abstract:Fig. S2 is about the cytotoxic effect of Zt/g4-MMAE on a panel of TNBC cell lines
Data from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Tyler J. Lahusen,Chu-Xia Deng

DOI: https://doi.org/10.1158/1535-7163.c.6536892.v1

2023-01-01

Abstract:AbstractSRT1720 is an activator of SIRT1, a NAD+-dependent protein and histone deacetylase that plays an important role in numerous biologic processes. Several studies have illustrated that SRT1720 treatment could improve metabolic conditions in mouse models and in a study in cancer SRT1720 caused increased apoptosis of myeloma cells. However, the effect of SRT1720 on cancer may be complex, as some recent studies have demonstrated that SRT1720 may not directly activate SIRT1 and another study showed that SRT1720 treatment could promote lung metastasis. To further investigate the role of SRT1720 in breast cancer, we treated SIRT1 knockdown and control breast cancer cell lines with SRT1720 both in vitro and in vivo. We showed that SRT1720 more effectively decreased the viability of basal-type MDA-MB-231 and BT20 cells as compared with luminal-type MCF-7 breast cancer cells or nontumorigenic MCF-10A cells. We demonstrated that SRT1720 induced lysosomal membrane permeabilization and necrosis, which could be blocked by lysosomal inhibitors. In contrast, SRT1720-induced cell death occurred in vitro irrespective of SIRT1 status, whereas in nude mice, SRT1720 exhibited a more profound effect in inhibiting the growth of allograft tumors of SIRT1 proficient cells as compared with tumors of SIRT1-deficient cells. Thus, SRT1720 causes lysosomal-dependent necrosis and may be used as a therapeutic agent for breast cancer treatment. Mol Cancer Ther; 14(1); 183–92. ©2014 AACR.
Supplementary Figure 5 from RON Receptor Tyrosine Kinase As a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Sreedhar Reddy Suthe,Hang-Ping Yao,Tian-Hao Weng,Chen-Yu Hu,Liang Feng,Zhi-Gang Wu,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22505493

2023-01-01

Abstract:Fig. S5 is about the effect of Zt/g4-MMAE on tumor weight and number.
Supplementary Figure 1 from RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Sreedhar Reddy Suthe,Hang-Ping Yao,Tian-Hao Weng,Chen-Yu Hu,Liang Feng,Zhi-Gang Wu,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22505505

2023-01-01

Abstract:Fig. S1 is about the HIC analysis of Zt/g4-MMAE and its stability in PBS
Supplementary Figure 3 from the Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth

Zhongguang Luo,Guangyang Yu,Hyuk Woo Lee,Lihui Li,Lingyan Wang,Dongqin Yang,Yongfu Pan,Chan Ding,Jing Qian,Lijun Wu,Yiwei Chu,Jing Yi,Xiangdong Wang,Yi Sun,Lak Shin Jeong,Jie Liu,Lijun Jia

DOI: https://doi.org/10.1158/0008-5472.22393793

2023-01-01

Abstract:PDF file - 1MB, MLN4924 induced more apoptosis in MEF-Atg7-KO compared to MEF-Atg7-WT
Supplementary Figure 3 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Jessica L. Schwartz-Roberts,Katherine L. Cook,Chun Chen,Ayesha N. Shajahan-Haq,Margaret Axelrod,Anni Wärri,Rebecca B. Riggins,Lu Jin,Bassem R. Haddad,Bhaskar V. Kallakury,William T. Baumann,Robert Clarke

DOI: https://doi.org/10.1158/0008-5472.22406517

2023-01-01

Abstract:Silencing ATG7 and BECN1 induces IRF1 expression independently of ROS.
Supplementary Figure 6 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Jessica L. Schwartz-Roberts,Katherine L. Cook,Chun Chen,Ayesha N. Shajahan-Haq,Margaret Axelrod,Anni Wärri,Rebecca B. Riggins,Lu Jin,Bassem R. Haddad,Bhaskar V. Kallakury,William T. Baumann,Robert Clarke

DOI: https://doi.org/10.1158/0008-5472.22406508.v1

2023-01-01

Abstract:Efficient knockdown of IRF1 using siRNA.
Supplementary Figure 3 from Fra-1 Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Dan Lu,Si Chen,Xiaoyue Tan,Na Li,Chenghu Liu,Zongjin Li,Ze Liu,Dwayne G. Stupack,Ralph A. Reisfeld,Rong Xiang

DOI: https://doi.org/10.1158/0008-5472.22393304

2023-01-01

Abstract:PDF file - 159K, Cell proliferation was evaluated by cell cycle analysis. Cell cycle profiles of 4TO7 cells with Fra-1 extinction (A) and ectopic expression (B) were confirmed by FACS. Cells were fixed by 70% ethanol, incubated in PBS buffer with RNase A and then stained with propidium iodide (PI) overnight. Data were collected on the following day
Supplementary Figure 2 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Jessica L. Schwartz-Roberts,Katherine L. Cook,Chun Chen,Ayesha N. Shajahan-Haq,Margaret Axelrod,Anni Wärri,Rebecca B. Riggins,Lu Jin,Bassem R. Haddad,Bhaskar V. Kallakury,William T. Baumann,Robert Clarke

DOI: https://doi.org/10.1158/0008-5472.22406520.v1

2023-01-01

Abstract:Nuclear IRF1 is induced following ATG7 and BECN1 knockdown.
Additional File 3: Figure S3. of ATF-3/miR-590/GOLPH3 Signaling Pathway Regulates Proliferation of Breast Cancer

Qiong Song,Chen Qiu,Qimin Wang,Longqiu Yang,Dongdong Lv,Guangli Jin,Jiaying Liu,Baolin Li,Xuejie Fei

DOI: https://doi.org/10.6084/m9.figshare.5980930.v1

2018-01-01

Abstract:Related to Fig. 6. ATF-3/miR-590-3p/Golph3 regulates the proliferation of MCF-7 cells (A) MTS proliferation assay showed overexpression of ATF-3 could rescue miR-590-3p repressing cell proliferation during 24, 48, 72 h in MCF-7. Data shown are means ± SD (n = 3), **P
Supplementary Figure 1 from Fra-1 Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Dan Lu,Si Chen,Xiaoyue Tan,Na Li,Chenghu Liu,Zongjin Li,Ze Liu,Dwayne G. Stupack,Ralph A. Reisfeld,Rong Xiang

DOI: https://doi.org/10.1158/0008-5472.22393310.v1

2023-01-01

Abstract:PDF file - 2.1MB, Human breast cancer cells were treated with CTX (500uM) for 24hrs and the apoptosis were evaluated by Annexin V and PI double staining (A). Fra-1 expression in these breast cancer cells were detected by Western-blot (B)
Supplementary Figure 5 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Jessica L. Schwartz-Roberts,Katherine L. Cook,Chun Chen,Ayesha N. Shajahan-Haq,Margaret Axelrod,Anni Wärri,Rebecca B. Riggins,Lu Jin,Bassem R. Haddad,Bhaskar V. Kallakury,William T. Baumann,Robert Clarke

DOI: https://doi.org/10.1158/0008-5472.22406511.v1

2023-01-01

Abstract:dnIRF1 blocks ICI sensitivity in LCC1 cells.
Supplementary Figure 2 from &Lt;i>fra-1&Lt;/i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Dan Lu,Si Chen,Xuezhi Tan,Na Li,Chenghu Liu,Zongjin Li,Ze Liu,Dwayne G. Stupack,Ralph A. Reisfeld,Rong Xiang

DOI: https://doi.org/10.1158/0008-5472.22393307.v1

2023-01-01

Abstract:PDF file - 75K, Cell proliferation was evaluated by staining of Ki-67 and Ki-67 expression in 4TO7-Fra-1 cells (A) as well as 4TO7-sh1 and 4TO7-sh2 cells (B) was measured by FACS. The expression of Ki-67 was quantified by mean fluorescence intensity. Error bars represent mean � SD, #p=0.12, *p <0.05, versus control group
Supplementary Figure 2 from SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma Via BCL2-Associated X Protein–Dependent Apoptotic Pathway

Long-Kuan Ran,Yong Chen,Zhenzhen Zhang,Na-Na Tao,Ji-Hua Ren,Zhou Li,Hua Tang,Xiang Chen,Ke Chen,Wanyu Li,Aiping Huang,Juan Chen

DOI: https://doi.org/10.1158/1078-0432.22455327.v1

2023-01-01

Abstract:SIRT6 depletion increased cell sensitivity to doxorubicin. Cells in different groups with or without doxorubicin treatment were subjected to flow cytometry with Annexin V/PI (A) and to PARP cleavage analysis (B). *, p<0.01.
Supplementary Figure 2 from Fra-1 Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Dan Lu,Si Chen,Xiaoyue Tan,Na Li,Chenghu Liu,Zongjin Li,Ze Liu,Dwayne G. Stupack,Ralph A. Reisfeld,Rong Xiang

DOI: https://doi.org/10.1158/0008-5472.22393307.v1

2023-01-01

Abstract:PDF file - 75K, Cell proliferation was evaluated by staining of Ki-67 and Ki-67 expression in 4TO7-Fra-1 cells (A) as well as 4TO7-sh1 and 4TO7-sh2 cells (B) was measured by FACS. The expression of Ki-67 was quantified by mean fluorescence intensity. Error bars represent mean � SD, #p=0.12, *p <0.05, versus control group
Supplementary Fig. S8 from Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell–Secreted Cytokines

Yoshinaga Ito,Deng Pan,Wubing Zhang,Xixi Zhang,Tiffany Y. Juan,Jason W. Pyrdol,Oleksandr Kyrysyuk,John G. Doench,X. Shirley Liu,Kai W. Wucherpfennig

DOI: https://doi.org/10.1158/2159-8290.22758761.v1

2023-01-01

Abstract:Supplementary Fig. S8 shows CD8 T cell-dependent control of tumors containing a B2m-/- population with inactivated Rnf31 and Atg5 genes.
Supplementary Table 2 from Interferon Regulatory Factor-1 Signaling Regulates the Switch between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Jessica L. Schwartz-Roberts,Katherine L. Cook,Chun Chen,Ayesha N. Shajahan-Haq,Margaret Axelrod,Anni Wärri,Rebecca B. Riggins,Lu Jin,Bassem R. Haddad,Bhaskar V. Kallakury,William T. Baumann,Robert Clarke

DOI: https://doi.org/10.1158/0008-5472.22406499

2023-01-01

Abstract:Relationship between IRF1 and ATG7 in human tissue microarrays.

Supplementary Figure 5 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Figure 2 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Supplementary Figure 2 from RON Receptor Tyrosine Kinase As a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Data from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Supplementary Figure 5 from RON Receptor Tyrosine Kinase As a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Supplementary Figure 1 from RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Supplementary Figure 3 from the Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth

Supplementary Figure 3 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplementary Figure 6 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplementary Figure 3 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 2 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Additional File 3: Figure S3. of ATF-3/miR-590/GOLPH3 Signaling Pathway Regulates Proliferation of Breast Cancer

Supplementary Figure 1 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 5 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplementary Figure 2 from &Lt;i>fra-1&Lt;/i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 2 from SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma Via BCL2-Associated X Protein–Dependent Apoptotic Pathway

Supplementary Figure 2 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Fig. S8 from Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell–Secreted Cytokines

Supplementary Table 2 from Interferon Regulatory Factor-1 Signaling Regulates the Switch between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplementary Figure 5 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Figure 2 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Supplementary Figure 2 from RON Receptor Tyrosine Kinase As a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Data from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Supplementary Figure 5 from RON Receptor Tyrosine Kinase As a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Supplementary Figure 1 from RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Supplementary Figure 3 from the Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth

Supplementary Figure 3 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplementary Figure 6 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplementary Figure 3 from &lt;i&gt;Fra-1&lt;/i&gt; Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 2 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Additional File 3: Figure S3. of ATF-3/miR-590/GOLPH3 Signaling Pathway Regulates Proliferation of Breast Cancer

Supplementary Figure 1 from &lt;i&gt;Fra-1&lt;/i&gt; Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 5 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplementary Figure 2 from &Lt;i&gt;fra-1&Lt;/i&gt; Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 2 from SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma Via BCL2-Associated X Protein–Dependent Apoptotic Pathway

Supplementary Figure 2 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Fig. S8 from Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell–Secreted Cytokines

Supplementary Table 2 from Interferon Regulatory Factor-1 Signaling Regulates the Switch between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplementary Figure 3 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 1 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 2 from &Lt;i>fra-1&Lt;/i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy